Maxona Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Maxona is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain. It is developing MAX-001 as the first novel therapeutic alternative to opioids and NSAIDs for the treatment of pain. While the U.S. is currently experiencing an opioid abuse epidemic, there has been very limited innovation to address the needs of millions of Americans suffering from acute and chronic pain. Hence, there is a significant need for safe and efficacious alternative analgesics. MAX-001 is an ex-US marketed non-opioid, non-NSAID analgesic New Molecular Entity that aims to fundamentally address the shortcomings of existing therapies. The company was founded in 2015 and is based in King of Prussia, Pennsylvania.
Maxona Pharmaceuticals has raised $5.6M across 1 funding round on record, the most recent an undisclosed round of $5.6M announced in May 2021.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Maxona Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: May 2021.
Maxona Pharmaceuticals Funding Rounds
Maxona Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Maxona Pharmaceuticals Funding Compared to Other Biotechnology Startups
Maxona Pharmaceuticals' latest round of $5.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Maxona Pharmaceuticals in Biotechnology and King Of Prussia
Companies Similar to Maxona Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Maxona Pharmaceuticals Funding FAQs
What does Maxona Pharmaceuticals do?
Maxona is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain. It is developing MAX-001 as the first novel therapeutic alternative to opioids and NSAIDs for the treatment of pain. While the U.S. is currently experiencing an opioid abuse epidemic, there has been very limited innovation to address the needs of millions of Americans suffering from acute and chronic pain. Hence, there is a significant need for safe and efficacious alternative analgesics. MAX-001 is an ex-US marketed non-opioid, non-NSAID analgesic New Molecular Entity that aims to fundamentally address the shortcomings of existing therapies. The company was founded in 2015 and is based in King of Prussia, Pennsylvania.
How much funding has Maxona Pharmaceuticals raised?
Maxona Pharmaceuticals has raised $5.6M across 1 round on record. The most recent is an undisclosed round of $5.6M announced in May 2021.
When did Maxona Pharmaceuticals last raise funding?
Maxona Pharmaceuticals' most recent funding round on record is an undisclosed round of $5.6M, announced in May 2021.
Who is the CEO of Maxona Pharmaceuticals?
Shawn Fatholahi is listed as CEO at Maxona Pharmaceuticals.
Where is Maxona Pharmaceuticals headquartered?
Maxona Pharmaceuticals is based in King Of Prussia, Pennsylvania, United States.
How many employees does Maxona Pharmaceuticals have?
Maxona Pharmaceuticals is in the 1-10 employee band.
How does Maxona Pharmaceuticals' funding compare to other Biotechnology startups?
Maxona Pharmaceuticals' latest round of $5.6M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Maxona Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Maxona Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.